A potential role for resveratrol as a radiation sensitizer for melanoma treatment

Journal of Surgical Research

Volumn 183, Issue 2, 2013, Pages 645-653

  Fang, Yujiang ^a,b   Bradley, Moore J ^a   Cook, Kathryn M ^a   Herrick, Elizabeth J ^a   Nicholl, Michael B ^a,b  

^a University of Missouri   (United States)

^b UNIVERSITY OF MISSOURI   (United States)

Author keywords

Apoptosis; Proliferation; Radiation; Resveratrol

Indexed keywords

CYCLIN B; CYCLIN D; CYCLIN DEPENDENT KINASE 2; CYCLIN DEPENDENT KINASE 4; CYCLINE; FLICE INHIBITORY PROTEIN; PROTEIN BCL 2; RESVERATROL; SURVIVIN;

APOPTOSIS; ARTICLE; CANCER RADIOTHERAPY; CELL PROLIFERATION; DRUG MECHANISM; HUMAN; HUMAN CELL; INTERMETHOD COMPARISON; MELANOMA; MOLECULAR MECHANICS; PRIORITY JOURNAL; PROTEIN EXPRESSION;

APOPTOSIS; PROLIFERATION; RADIATION; RESVERATROL;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; APOPTOSIS; CASPASE 3; CELL LINE, TUMOR; CELL PROLIFERATION; COMBINED MODALITY THERAPY; CYCLIN D; DRUG THERAPY; HUMANS; INHIBITOR OF APOPTOSIS PROTEINS; MELANOMA; PROTO-ONCOGENE PROTEINS C-BCL-2; RADIATION-SENSITIZING AGENTS; RADIOTHERAPY; SKIN NEOPLASMS; STILBENES;

EID: 84880314097     PISSN: 00224804     EISSN: 10958673     Source Type: Journal    
DOI: 10.1016/j.jss.2013.02.037     Document Type: Article

References (43)

1. N. Khan, M.K. Khan, and A. Almasan The evolving role of radiation therapy in the management of malignant melanoma Int J Radiat Oncol Biol Phys 80 2011 645
2. R. Siegel, E. Ward, and A. Jemal Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths CA Cancer J Clin 61 2011 212
3. M.B. Nicholl, D. Elashoff, and H. Takeuchi Molecular upstaging based on paraffin-embedded sentinel lymph nodes: ten-year follow-up confirms prognostic utility in melanoma patients Ann Surg 253 2011 116
4. P.B. Chapman, A. Hauschild, and C. Robert Improved survival with vemurafenib in melanoma with BRAF V600E mutation N Engl J Med 364 2011 2507
5. F.S. Hodi, S.J. O'Day, and D.F. McDermott Improved survival with ipilimumab in patients with metastatic melanoma N Engl J Med 363 2010 711
6. F.C. Beddingfield III The melanoma epidemic: res ipsa loquitur Oncologist 8 2003 459
7. C.M. Balch, S.J. Soong, and J.E. Gershenwald Prognostic factors analysis of 17,600 melanoma patients: validation of the American Joint Committee on Cancer melanoma staging system J Clin Oncol 19 2001 3622
8. E. Bastiaannet, J.C. Beukema, and H.J. Hoekstra Radiation therapy following lymph node dissection in melanoma patients: treatment, outcome and complications Cancer Treat Rev 31 2005 18
9. C. Perlis, and M. Herlyn Recent advances in melanoma biology Oncologist 9 2004 182
10. E. Atallah, and L. Flaherty Treatment of metastatic malignant melanoma Curr Treat Options Oncol 6 2005 185
11. M.B. Atkins Cytokine-based therapy and biochemotherapy for advanced melanoma Clin Cancer Res 12 2006 2353s
12. M. Jang, L. Cai, and G.O. Udeani Cancer chemopreventive activity of resveratrol, a natural product derived from grapes Science 275 1997 218
13. P. Cos, T. De Bruyne, and S. Apers Phytoestrogens: recent developments Planta Med 69 2003 589
14. J.L. Ingham 3,5,4'-Trihydroxystilbene as a phytoalexin from groundnuts (Arachis hypogea) Phytochem 15 1976 1791
15. F. Casanova, J. Quarti, and D.C. da Costa Resveratrol chemosensitizes breast cancer cells to melphalan by cell cycle arrest J Cell Biochem 113 2012 2586
16. J.C. Morris Resveratrol, thyroid cancer, and iodide: drink up? Thyroid 20 2010 125
17. A. Tyagi, M. Gu, and T. Takahata Resveratrol selectively induces DNA Damage, independent of Smad4 expression, in its efficacy against human head and neck squamous cell carcinoma Clin Cancer Res 17 2011 5402
18. Y.J. Surh, Y.J. Hurh, and J.Y. Kang Resveratrol, an antioxidant present in red wine, induces apoptosis in human promyelocytic leukemia (HL-60) cells Cancer Lett 140 1999 1
19. H. Miki, N. Uehara, and A. Kimura Resveratrol induces apoptosis via ROS-triggered autophagy in human colon cancer cells Int J Oncol 40 2012 1020
20. S. Shishodia, and B.B. Aggarwal Resveratrol: a polyphenol for all seasons 2006 CRC Press Taylor and Francis Boca Raton, FL p.1
21. A. Bhardwaj, G. Sethi, and S. Vadhan-Raj Resveratrol inhibits proliferation, induces apoptosis, and overcomes chemoresistance through down-regulation of STAT3 and nuclear factor-κB-regulated antiapoptotic and cell survival gene products in human multiple myeloma cells Blood 109 2007 2293
22. Y. Fang, V.G. DeMarco, and M.B. Nicholl Resveratrol enhances radiation sensitivity in prostate cancer by inhibiting cell proliferation and promoting cell senescence and apoptosis Cancer Sci 103 2012 1090
23. Y. Fang, E.J. Herrick, and M.B. Nicholl A possible role for perforin and granzyme B in resveratrol enhanced radiosensitivity of prostate cancer J Androl 33 2012 752
24. M.V. Berridge, A.S. Tan, and K.D. McCoy The biochemical and cellular basis of cell proliferation assays that use tetrazolium salts Biochemica 4 1996 12
25. Y. Fang, Y. Wei, and V. DeMarco Murine FLIP transgene expressed on thyroid epithelial cells promotes resolution of granulomatous experimental autoimmune thyroiditis Am J Pathol 171 2007 875
26. Y. Fang, G.C. Sharp, and H. Yagita A critical role for TRAIL in resolution of granulomatous experimental autoimmune thyroiditis J Pathol 216 2008 505
27. Y. Fang, S. Yu, and J.S. Ellis Comparison of sensitivity of Th1, Th2 and Th17 cells to Fas-mediated apoptosis J Leuk Biol 87 2010 1019
28. V.N. Ivanov, M.A. Partridge, and G.E. Johnson Resveratrol sensitizes melanomas to TRAIL through modulation of antiapoptotic gene expression Exp Cell Res 314 2008 1163
29. O. Vang, N. Ahmad, and C.A. Baile What is new for an old molecule? Systematic review and recommendations on the use of resveratrol PLOS One 6 2011 e19881
30. D.G. Johnson, and C.L. Walker Cyclins and cell cycle checkpoints Annu Rev Pharmacol Toxicol 39 1999 295
31. C.J. Sherr G1 phaseprogression: cycling on cue Cell 79 1994 551
32. C.J. Sherr D-type cyclins Trends Biochem Sci 20 1995 187
33. F. Scarlati, G. Sala, and C. Ricci Resveratrol sensitization of DU145 prostate cancer cells to ionizing radiation is associated to ceramide increase Cancer Lett 253 2007 124
34. G.E. Johnson, V.N. Ivanov, and T.K. Hei Radiaosensitiztion of melanoma cells through combined inhibition of protein regulators of cell survival Apoptosis 13 2008 790
35. C.B. Thompson Apoptosis in the pathogenesis and treatment of disease Science 267 1995 1456
36. T.S. Griffith, T. Brunner, and S.M. Fletcher Fas ligand-induced apoptosis as a mechanism of immune privilege Science 270 1995 1189
37. H. Zhang, Q. Xu, and S. Krajewski BAR: an apoptosis regulator at the intersection of caspases and Bcl-2 family proteins Proc. Natl Acad Sci USA 97 2000 2597
38. N.K. Sah, Z. Khan, and G.J. Khan Structural, functional and therapeutic biology of survivin Cancer Lett 244 2006 164
39. H. Yamamoto, C.Y. Ngan, and M. Monden Cancer cells survive with survivin Cancer Sci 99 2008 1709
40. D.C. Altieri Survivin, cancer networks and pathway-directed drug discovery Nat Rev Cancer 8 2008 61
41. R.M. Snyder, W. Yu, and L. Jia Vitamin E analog alpha-TEA, methylseleninic acid, and trans-resveratrol in combination synergistically inhibit human breast cancer cell growth Nutr Cancer 60 2008 401
42. V.N. Ivanov, and T.K. Hei Sodium arsenite accelerates TRAIL-mediated apoptosis in melanoma cells through upregulation of TRAIL-R1/R2 surface levels and downregulation of cFLIP expression Exp Cell Res 312 2006 4120
43. L. Chang, H. Kamata, and G. Solinas The E3 ubiquitin ligase itch couples JNK activation to TNFalpha-induced cell death by inducing c-FLIP(L) turnover Cell 124 2006 601